TBI-AD/ADRD Caregiver Support Intervention (TACSI) for Caregiver Burden

Phase-Based Progress Estimates
University of Minnesota, Minneapolis, MN
Caregiver Burden+2 More
TBI-AD/ADRD Caregiver Support Intervention (TACSI) - Other
All Sexes
What conditions do you have?

Study Summary

The TBI-AD/ADRD Caregiver Support Intervention (TACSI) incorporates psychosocial and psychoeducational approaches with the objective of: a) identifying stressors associated with caregiving for family members who have the dual diagnosis of traumatic brain injury and dementia; and b) supporting caregivers in developing more effective coping and communication strategies as well as enhanced caregiving self-efficacy.

Eligible Conditions

  • Caregiver Burden
  • Caregivers Burnout
  • Caregiver Stress Syndrome

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 0 Secondary · Reporting Duration: change in score from baseline to 6 months

Month 3
Caregiver primary subjective stress- Phase 1
Caregiver primary subjective stress- Phase 2, 3mo
Month 6
Caregiver primary subjective stress- Phase 2, 6mo

Trial Safety

Trial Design

2 Treatment Groups

Usual care control group
1 of 2
1 of 2
Active Control
Experimental Treatment

95 Total Participants · 2 Treatment Groups

Primary Treatment: TBI-AD/ADRD Caregiver Support Intervention (TACSI) · No Placebo Group · N/A

Experimental Group · 1 Intervention: TBI-AD/ADRD Caregiver Support Intervention (TACSI) · Intervention Types: Other
Usual care control groupNoIntervention Group · 1 Intervention: Usual care control group · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: change in score from baseline to 6 months
Closest Location: University of Minnesota · Minneapolis, MN
Photo of University of Minnesota   1Photo of University of Minnesota   2Photo of University of Minnesota  3
1993First Recorded Clinical Trial
1 TrialsResearching Caregiver Burden
827 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a physician diagnosis of TBI and AD/ADRD (i.e.
You have a caregiver who is 21 years of age or older.
You are a US citizen or resident.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.